IMLYGIC sol inj 100 mio UFP/ml flac 1 ml

7680658120027 CH-65812 L01XL02 07.16.

Reimbursement limitations:

IMLYGIC2

IMLYGIC est pris en charge en monothérapie, pour le traitement locale de première intention des …

IMLYGIC sol inj 100 mio UFP/ml flac 1 ml
IMLYGIC sol inj 100 mio UFP/ml flac 1 ml
IMLYGIC sol inj 100 mio UFP/ml flac 1 ml
1 / 3
google

Details

Product number
6581202
CPT
-
Packaging group
1 ml
Unit
Durchstechflasche(n)
Composition
Lösung: talimogenum laherparepvecum 100 Million U..

Articles (1)

Imlygic 10e8, Injektionslösung
Injektionslösung
1 ml
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
08/05/2025
Patient information leaflet
Français
08/05/2025
Patient information leaflet
Italien
08/05/2025
Professional SmPC
Allemand
08/05/2025
Professional SmPC
Français
08/05/2025
Professional SmPC
Italien
08/05/2025

Detailed composition

Substance Quantity Type Category
SOLU
- Substance Wirkstoff (Principe actif)

Reimbursement information

Public price
CHF 2233.85
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/12/2017

Authorization holder

Amgen Switzerland AG

6343 Risch

Authorization information

Swissmedic authorization number
65812
Drug name
Imlygic, Injektionslösung
Galenic form
LSPA
ATC Code
L01XL02
Authorization status
Z
Dispensation category
A
First authorization
13/07/2016
Authorization expiration date
31/12/9999
IT number
07.16.
Domain
Human medicine
Field of application
Imlygic ist zur Behandlung von Melanomen mit regionalen oder entfernten Metastasen bei Erwachsenen indiziert.

Packaging details

Description (FR)
IMLYGIC sol inj 100 mio UFP/ml flac 1 ml
Description (DE)
IMLYGIC Inj Lös 100 Mio PFU/ml Durchstf 1 ml
Market launch
13/07/2016
Narcotic (BTM)
No

Application methods

ILES

Other packaging sizes

IMLYGIC sol inj 1 mio UFP/ml flac 1 ml
1 ml DUR
GTIN: 7680658120010
View